Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Finamore

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
ACS Omega|June 9, 2025
Exploring Boswellia serrata Triterpenes: A New Frontier in Leukemia Inhibitory Factor Receptor ModulationClaudia Finamore, Carmen Festa, Mattia Cammarota, et al.
ACS Omega|December 4, 2023
Correction to "Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders"Bianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
ACS Omega|February 23, 2023
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated DisordersBianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver InjuryValentina Sepe, Silvia Marchianò, Claudia Finamore, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against ColitisSimona De Marino, Claudia Finamore, Michele Biagioli, et al.
Journal of Medicinal Chemistry|October 9, 2024
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver FibrosisPasquale Rapacciuolo, Claudia Finamore, Cristina Di Giorgio, et al.
Biochemical Pharmacology|March 17, 2024
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesisCristina Di Giorgio, Elva Morretta, Antonio Lupia, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Omega|June 9, 2025
Exploring Boswellia serrata Triterpenes: A New Frontier in Leukemia Inhibitory Factor Receptor ModulationClaudia Finamore, Carmen Festa, Mattia Cammarota, et al.
ACS Omega|December 4, 2023
Correction to "Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders"Bianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
ACS Omega|February 23, 2023
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated DisordersBianca Fiorillo, Rosalinda Roselli, Claudia Finamore, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver InjuryValentina Sepe, Silvia Marchianò, Claudia Finamore, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against ColitisSimona De Marino, Claudia Finamore, Michele Biagioli, et al.
Journal of Medicinal Chemistry|October 9, 2024
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver FibrosisPasquale Rapacciuolo, Claudia Finamore, Cristina Di Giorgio, et al.
Biochemical Pharmacology|March 17, 2024
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesisCristina Di Giorgio, Elva Morretta, Antonio Lupia, et al.
Pageof 3